Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (51)
  • 2024 (40)
  • 2023 (76)
  • 2022 (86)
  • 2021 (70)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4012)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Museum and Visitors Center (3)

Drug Name

  • Oxycodone (75)
  • Opioids (57)
  • Fentanyl (53)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Benzodiazepines (13)
  • Methamphetamine (13)
  • Morphine (10)
  • Amphetamines (9)
  • Cocaine (8)
  • Heroin (6)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (46)
  • St. Louis (39)
  • New York (34)
  • New England (24)
  • Seattle (23)
  • Headquarters (22)
  • Atlanta (19)
  • Miami (18)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (13)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Six Arrested for Multi-State Drug Conspiracy Spanning Massachusetts, Rhode Island and Texas

July 14, 2023
BOSTON – Six individuals were arrested today for their alleged involvement in a drug trafficking organization that distributed oxycodone pills obtained from a source in the Houston area, across Southeastern Massachusetts and beyond. John Campbell, a/k/a Jizz, 40, of Taunton, Mass. was charged with one count of conspiracy to distribute...
July 14, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

July 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
July 06, 2023
PRESS RELEASE

Boise Nurse Practitioner and Patient/Medical Assistant Charged with Conspiracy to Distribute Opioids

June 30, 2023
BOISE – U.S. Attorney Josh Hurwit announced criminal charges against two defendants today as part of the Department of Justice’s 2023 National Health Care Fraud Enforcement Action. This two-week nationwide law enforcement action resulted in criminal charges against 78 defendants for their alleged participation in health care fraud and opioid...
June 30, 2023
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

June 26, 2023
NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
June 26, 2023
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

June 26, 2023
CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
June 26, 2023
PRESS RELEASE

Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return

June 23, 2023
TAMPA , F la. – United States Attorney Roger B. Handberg announced that a federal jury found Dr. Qing McGaha guilty of 14 counts of unlawful drug distribution, four (4) counts of money laundering, and one (1) count of filing a false tax return. McGaha faces a maximum penalty of...
June 23, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

June 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
June 23, 2023
PRESS RELEASE

San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids

June 22, 2023
SAN JOSE, Calif. – A federal jury yesterday convicted family medicine physician Donald Siao of twelve counts of distributing the controlled substances Oxycodone and Hydrocodone outside the scope of his usual professional practice and without a legitimate medical purpose, announced United States Attorney Ismail J. Ramsey, Drug Enforcement Administration (DEA)...
June 22, 2023
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

June 22, 2023
ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
June 22, 2023
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

June 16, 2023
ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
June 16, 2023
Showing 131 - 140 of 366 results

Pagination

  • First page «
  • Previous page ‹
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster